Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Treasury Shares (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Treasury Shares for 3 consecutive years, with $500000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $500000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $500000.0, a 0.0% change, with the full-year FY2024 number at $500000.0, up 296.83% from a year prior.
  • Treasury Shares was $258425.0 for Q3 2025 at Plus Therapeutics, up from -$258425.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $258425.0 in Q4 2024 to a low of -$258425.0 in Q1 2024.
  • A 3-year average of -$106729.2 and a median of -$258425.0 in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: soared 296.83% in 2024, then changed 0.0% in 2025.
  • Plus Therapeutics' Treasury Shares stood at $126000.0 in 2023, then skyrocketed by 296.83% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Treasury Shares are $500000.0 (Q3 2025), $500000.0 (Q2 2025), and $500000.0 (Q1 2025).